Skip to content

Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase

Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02566629
Enrollment
30
Registered
2015-10-02
Start date
2015-07-31
Completion date
2015-11-30
Last updated
2015-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Keywords

microbiota community, IBS

Brief summary

Analyze microbiota community of irritable bowel syndrome in episodes phase and remission phase.

Detailed description

The pathophysiology of IBS is incompletely understood, it may involve an altered intestinal microbiota. Since the microflora composition of IBS is various in different studies, The investigators plan to compare the intestinal microbiota of IBS patients in episodes phase and remission phase with healthy controls,trying to find the difference.

Interventions

OTHERcollect faeces from participants

analyze the fecal microbiota community using 16S rDNA detection technique

Sponsors

Shandong University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* the presence of Rome III criteria for IBS ; * Patients scheduled for colonoscopy examination or having negative screening examinations * Aged between 18 and 65 years old

Exclusion criteria

* Antibiotic, probiotic or laxative usage within 4 weeks. * organic gastrointestinal diseases * Severe systematic disease: diabetes mellitus, hepatic, renal or cardiac dysfunction, thyroid disease or tumor etc. * pregnancy or lactation. * previous major or complicated abdominal surgery. * severe endometriosis and dementia

Design outcomes

Primary

MeasureTime frame
microbiota community among IBS patients in episodes phase,remission phase and healthy controls5 months

Secondary

MeasureTime frame
quality of life in IBS patients5 months

Countries

China

Contacts

Primary ContactYanqing Li, MD.PhD
liyanqing@sdu.edu.cn86-531-82169236

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026